PRICING SUPPLEMENT DATED JULY 22, 2003 Rule 424(b)(3)
- -------------------------------------- File No. 333-105098
(To Prospectus Supplement and Prospectus
dated June 3, 2003)
Pricing Supplement Number: 2328
Merrill Lynch & Co., Inc.
Medium-Term Notes, Series B
Due Nine Months or More from Date of Issue
0.25% Callable and Exchangeable Notes
Linked to the Performance of MeadWestvaco Corporation Common Stock
due July 28, 2010
(the "Notes")
----------
The Notes are part of a series of senior debt securities entitled "Medium-Term Notes, Series B" as more fully
described in the attached Prospectus (which term includes the attached Prospectus Supplement). Information included
in this Pricing Supplement supercedes information in the Prospectus to the extent it is different from the
information included in the Prospectus.
References in this Pricing Supplement to "ML&Co.", "we", "us" and "our" are to Merrill Lynch & Co., Inc., and
references to "MLPF&S" are to Merrill Lynch, Pierce, Fenner & Smith Incorporated.
Investing in the Notes involves risks that are described in the "Risk Factors" section of this Pricing
Supplement and the accompanying Prospectus Supplement.
Aggregate principal amount................... $13,000,000
Stated Maturity Date......................... July 28, 2010
Issue Price.................................. $1,000 per Note
Original Issue Date.......................... July 28, 2003
Interest Rate................................ 0.25% per annum on the principal amount of each Note, payable
semi-annually in arrears.
Interest Payment Dates....................... January 28 and July 28 of each year, beginning January 28, 2004
and ending on the Stated Maturity Date. If any Interest Payment
Date falls on a day that is not a Business Day, any payment due on
such Interest Payment Date will be made on the immediately
succeeding Business Day and no additional interest will accrue as
a result of the delayed payment. Interest will be paid to the
persons in whose names the Notes are registered at the close of
business on the fifteenth calendar day preceding the related
Interest Payment Date, whether or not such fifteenth calendar day
is a Business Day.
Call Option.................................. We may call the Notes, in whole but not in part, on any Trading
Day beginning on July 28, 2005 to but excluding the third Trading
Day prior to the Stated Maturity Date (the day on which the call
occurs, if any, being the "Call Date") by giving notice to the
Trustee of the Notes five (5) Trading Days prior to the Call
Date.
Call Price................................... If we call the Notes, you will be entitled to receive the "Call
Price" which will be, for each $1,000 principal amount of the
Notes you own, a cash amount equal to the greater of:
(i) the product of the Exchange Ratio and the Exchange Value (each
P-1
as defined below under "Exchange Price"); or
(ii) $1,000 plus accrued and unpaid interest on your Notes to but
excluding the Call Date.
If the Call Price is based on the formula provided in (i) above,
you will not receive accrued and unpaid interest, if any, to such
Call Date.
Optional Exchange Right...................... The Notes are exchangeable for the Exchange Price at your option,
in whole or in part, on any Trading Day (as defined below)
beginning on July 28, 2003 to but excluding the third scheduled
Trading Day prior to the Stated Maturity Date (each such day on
which a Note is exchanged being an "Exchange Date") by giving
notice to the Trustee, as defined below, five (5) Trading Days
prior to such Exchange Date, so that the last date on which you
may give notice to the Trustee will be on the ninth scheduled
Trading Day prior to the Stated Maturity Date.
If you choose to exchange your Notes, you will be entitled to
receive the Exchange Price of such Notes on the third Business Day
after the Exchange Date, except if such third Business Day is on or
after the Stated Maturity Date, then on the Stated Maturity Date.
Exchange Price............................... For each $1,000 principal amount of Notes, the "Exchange Price"
shall be an amount in cash equal to:
Exchange Value x Exchange Ratio
You will not receive accrued and unpaid interest, if any, to the
Exchange Date.
The "Exchange Value", as determined by the Calculation Agent, will
equal the Closing Market Price (as defined below) of one share of
MeadWestvaco Corporation ("MeadWestvaco") common stock issued by
MeadWestvaco, which is currently traded on the New York Stock
Exchange ("NYSE") under the symbol "MWV", determined on the
Calculation Date.
The "Exchange Ratio" initially equals 36.0849 for each $1,000
principal amount of Notes and is subject to periodic adjustment as
described in this pricing supplement.
Amount Payable at Maturity................... If the Notes have not been called by us or exchanged by you prior
to the Stated Maturity Date, for each $1,000 principal amount of
Notes that you own at maturity, ML&Co. will pay an amount in cash
equal to $1,000 plus accrued and unpaid interest through but
excluding the maturity date.
Business Day................................. "Business Day" means, with respect to any day on which a payment
of interest is to be made, any day other than a Saturday or
Sunday, that is neither a legal holiday nor a day on which
commercial banks are authorized or required by law, regulation or
executive order to close in The City of New York.
Trading Day.................................. A day on which the NYSE, the American Stock Exchange and The
Nasdaq Stock Market are open for trading.
Calculation Date............................. "Calculation Date" for the purpose of an exchange or a call means
the Exchange Date or Call Date, as applicable, on which a Market
P-2
Disruption Event, as discussed below, has not occurred with respect
to MeadWestvaco common stock. If a Market Disruption Event occurs
on such day, then the Calculation Date shall be the next succeeding
scheduled Trading Day, regardless of the occurrence of a Market
Disruption Event on that scheduled Trading Day, provided, however,
that the Calculation Date shall not fall on any day after the third
scheduled Trading Day prior to the Stated Maturity Date.
Closing Market Price......................... "Closing Market Price" means that if MeadWestvaco common stock (or
any other security for which a closing market price must be
determined for purposes of the Notes) are listed on a national
securities exchange in the United States, are a Nasdaq National
Market System ("Nasdaq NMS") security or are included in the OTC
Bulletin Board Service ("OTC Bulletin Board") operated by the
National Association of Securities Dealers, Inc. (the "NASD"), then
the closing market price for any date of determination on any
Trading Day means for one share of MeadWestvaco common stock (or any
other security for which a closing market price must be determined
for purposes of the Notes):
o the last reported sale price, regular way, on that day on
the principal United States securities exchange registered
under the Exchange Act on which that security is listed or
admitted to trading (without taking into account any
extended or after-hours trading session), or
o if not listed or admitted to trading on any such
securities exchange or if the last reported sale price is
not obtainable, the last reported sale price on the
over-the-counter market as reported on the Nasdaq NMS or
OTC Bulletin Board on that day (without taking into
account any extended or after-hours trading session), or
o if the last reported sale price is not available for any
reason, including, without limitation, the occurrence of
a Market Disruption Event, as described below, the mean
of the last reported bid and offer price of the principal
trading session on the over-the-counter market as
reported on The Nasdaq Stock Market or OTC Bulletin Board
on that day as determined by the Calculation Agent or
from as many dealers in such security, but not exceeding
three, as have made the bid prices available to the
Calculation Agent after 3:00 p.m., local time in the
principal market, on that date (without taking into
account any extended or after-hours trading session).
If MeadWestvaco common stock (or any other security for which a closing
market price must be determined for purposes of the Notes) are not listed
on a national securities exchange in the United States, is not a Nasdaq
NMS security or included in the OTC Bulletin Board, then the closing market
price for any date of determination on any Trading Day means for each share
of MeadWestvaco common stock (or any other security for which a
closing market price must be determined for purposes of the Notes)
the last reported sale price on that day on the securities exchange
on
P-3
which that security is listed or admitted to trading with the
greatest volume of trading for the calendar month preceding such
Trading Day as determined by the calculation agent; provided that
if such last reported sale price is for a transaction which
occurred more than four hours prior to the close of that exchange,
then the closing market price shall mean the average (mean) of the
last available bid and offer price on that exchange.
If MeadWestvaco common stock (or any other security for which a
closing market price must be determined for purposes of the Notes)
are not listed or admitted to trading on any such securities exchange
or if such last reported sale price or bid and offer are not
obtainable, then the closing market price shall mean the average
(mean) of the last available bid and offer prices in such market of
the three dealers which have the highest volume of transactions in
that security in the immediately preceding calendar month as
determined by the calculation agent based on information that is
reasonably available to it.
CUSIP number................................. 59018YRQ6
ISIN......................................... US59018YRQ60
Form of Notes................................ Book-entry.
Denominations................................ We will issue and sell the Notes in denominations of $1,000 and
integral multiples of $1,000 in excess thereof.
Day Count Convention......................... 30/360
Trustee...................................... JPMorgan Chase Bank.
Calculation Agent............................ Merrill Lynch, Pierce, Fenner & Smith Incorporated
All determinations made by the Calculation Agent will be at the
sole discretion of the Calculation Agent and, absent manifest
error, will be conclusive for all purposes and binding on ML&Co.
and beneficial owners of the Notes.
All percentages resulting from any calculation on the Notes will be
rounded to the nearest one hundred-thousandth of a percentage
point, with five one-millionths of a percentage point rounded
upwards, e.g., 9.876545% (or .09876545) would be rounded to
9.87655% (or .0987655). All dollar amounts used in or resulting
from this calculation will be rounded to the nearest cent with
one-half cent being rounded upwards.
Proceeds to ML&Co............................ 100% of the aggregate principal amount.
P-4
RISK FACTORS
Your investment in the Notes will involve certain risks. You should
consider carefully the following discussion of risks before you decide that an
investment in the Notes is suitable for you.
The Notes are subject to being called at our option
We may call all of the Notes on any scheduled Trading Day beginning July
28, 2005 to and including the maturity date. In the event that we elect to
call the Notes, you may receive an amount that is less than the amount to
which you would otherwise have been entitled had you exchanged the Notes at a
later date.
Your yield may be lower than the yield on other standard debt securities of
comparable maturity
The yield that you will receive on your Notes, which could be negative,
may be less than the return you could earn on other investments. Your yield
may be less than the yield you would earn if you bought a standard senior
non-callable debt security of ML&Co. with the same stated maturity date. Your
investment may not reflect the full opportunity cost to you when you take into
account factors that affect the time value of money. Unlike standard senior
non-callable debt securities, the Notes do not guarantee the return of a
principal amount at maturity.
You will need to exchange your Notes to realize any appreciation from
increases in the market price of MeadWestvaco common stock
If the market price of MeadWestvaco common stock increases prior to
maturity such that the Exchange Amount would exceed the principal amount of
the Notes and ML&Co. has not elected to redeem the Notes, you will need to
exchange your Notes in order to realize such Exchange Price. If you do not
exchange your Notes, you will receive only the principal amount plus accrued
interest at maturity, which could be less than the Exchange Price you might
otherwise receive before maturity.
You will have no stockholder rights with respect to MeadWestvaco common stock
You will not be entitled to any rights with respect to MeadWestvaco
common stock, including, without limitation, the right to receive dividends or
other distributions, if any, on MeadWestvaco's common stock, or the right to
vote or to tender or exchange MeadWestvaco's common stock, in any tender or
exchange offer by MeadWestvaco or any third party.
A trading market for the Notes is not expected to develop
The Notes will not be listed on any securities exchange and we do not
expect a trading market for the Notes to develop. Although our affiliate
MLPF&S has indicated that it expects to bid for Notes offered for sale to it
by Note holders, it is not required to do so and may cease making such bids at
any time. The limited trading market for your Notes may affect the price that
you receive for your Notes if you do not wish to hold your investment until
maturity.
Many factors affect the value of the Notes; these factors interrelate in
complex ways and the effect of any one factor may offset or magnify the effect
of another factor
The value of the Notes will be affected by factors that interrelate in
complex ways. It is important for you to understand that the effect of one
factor may offset the increase in the value of the Notes caused by another
factor and that the effect of one factor may exacerbate the decrease in the
value of the Notes caused by another factor. For example, a change in U.S.
interest rates may offset some or all of any increase in the trading value of
the Notes attributable to another factor, such as an increase in the price of
MeadWestvaco common stock. The following paragraphs describe the expected
impact on the value of the Notes given a change in a specific factor, assuming
all other conditions remain constant.
P-5
The price of MeadWestvaco common stock is expected to affect the
trading value of the Notes. We expect that the market value of the Notes will
depend substantially on the price of MeadWestvaco common stock. However, you
generally should not expect the increase or decrease in the market value of
your Notes to be identical to the increase or decrease in the market value of
MeadWestvaco common stock. For example, if you choose to sell your Notes when
the price of MeadWestvaco common stock, when multiplied by the Exchange Ratio,
exceeds the principal amount, you may receive substantially less than the
current market value of MeadWestvaco common stock because of the expectation
that the price of MeadWestvaco common stock will continue to fluctuate until
the maturity date and the fact that the Notes are callable at the option of
ML&Co.
Changes in the levels of interest rates are expected to affect the
trading value of the Notes. We expect that changes in interest rates will
affect the trading value of the Notes. In general, if U.S. interest rates
increase, we expect that the trading value of the Notes will decrease and,
conversely, if U.S. interest rates decrease, we expect that the trading value
of the Notes will increase.
Changes in the volatility of MeadWestvaco common stock are expected
to affect the trading value of the Notes. Volatility is the term used to
describe the size and frequency of price and/or market fluctuations. If the
volatility of MeadWestvaco common stock increases, we expect the trading value
of the Notes will decrease; and, if the volatility of MeadWestvaco common
stock decreases, we expect that the trading value of the Notes will increase.
As the time remaining to maturity of the Notes decreases, the "time
premium or discount" associated with the Notes will decrease. We anticipate
that before their maturity, the Notes may trade at a value above or below that
which would be expected based on the level of interest rates and the price of
MeadWestvaco common stock. This difference will reflect a "time premium or
discount" due to expectations concerning the price of MeadWestvaco common
stock during the period before the stated maturity of the Notes. As the time
remaining to maturity decreases, any discount or premium attributed to the
trading value of the Notes will diminish, increasing or decreasing the trading
value of the Notes.
Changes in dividend yields of MeadWestvaco common stock are expected
to affect the trading value of the Notes. If the dividend yield on
MeadWestvaco common stock were to increase, we would expect the value of the
Notes to decrease. However, should there be a subsequent decrease in the
dividend yield on MeadWestvaco common stock, we would expect the value of the
Notes to increase.
Changes in our credit ratings may affect the trading value of the
Notes. Our credit ratings are an assessment of our ability to pay our
obligations. Consequently, real or anticipated changes in our credit ratings
may affect the trading value of the Notes. However, because your return on
your Notes is dependent upon factors in addition to our ability to pay our
obligations under the Notes, such as the percentage change in the price of
MeadWestvaco common stock at maturity, an improvement in our credit ratings
will not reduce the other investment risks related to the Notes.
In general, assuming all relevant factors are held constant, we expect
that the effect on the trading value of the Notes of a given change in most of
the factors listed above will be less if it occurs later in the term of the
Notes than if it occurs earlier in the term of the Notes. However, we expect
that the effect on the trading value of the Notes of a given change in the
price of MeadWestvaco common stock will be greater if it occurs later in the
term of the Notes than if it occurs earlier in the term of the Notes.
Amounts payable on the Notes may be limited by state law
New York State law governs the 1993 Indenture under which the Notes will
be issued. New York has usury laws that limit the amount of interest that can
be charged and paid on loans, which includes debt securities like the Notes.
Under present New York law, the maximum rate of interest is 25% per annum on a
simple interest basis. This limit may not apply to debt securities in which
$2,500,000 or more has been invested.
While we believe that New York law would be given effect by a state or
Federal court sitting outside of New York, many other states also have laws
that regulate the amount of interest that may be charged to and paid by a
borrower. We will promise, for the benefit of the holders of the Notes, to the
extent permitted by law, not to voluntarily claim the benefits of any laws
concerning usurious rates of interest.
P-6
Potential conflicts of interest could arise
Our subsidiary, MLPF&S, is our agent for the purposes of calculating any
and all amounts payable on the Notes. Under certain circumstances, MLPF&S'
role as our subsidiary and its responsibilities as Calculation Agent for the
Notes could give rise to conflicts of interest. MLPF&S is required to carry
out its duties as Calculation Agent in good faith and using its reasonable
judgment. However, you should be aware that because we control MLPF&S,
potential conflicts of interest could arise.
We have entered into an arrangement with one of our subsidiaries to hedge
the market risks associated with our obligation to pay amounts due at maturity
on the Notes. This subsidiary expects to make a profit in connection with this
arrangement. We did not seek competitive bids for this arrangement from
unaffiliated parties.
Tax consequences
You should consider the tax consequences of investing in the Notes. See
the section entitled "United States Federal Income Taxation" in this Pricing
Supplement.
P-7
EXCHANGE RATIO ADJUSTMENTS
The Exchange Ratio used to determine the Exchange Price or Call Price, as
the case may be, is subject to adjustment by the Calculation Agent as
described in this section.
No adjustments to the Exchange Ratio will be required unless the Exchange
Ratio adjustment would require a change of at least 0.1% in the Exchange Ratio
then in effect. The Exchange Ratio resulting from any of the adjustments
specified below will be rounded to the sixth decimal place with five
ten-millionths being rounded upward. The Calculation Agent will not be
required to make any adjustments to the Exchange Ratio after the close of
business on the fourth Business Day immediately prior to the Stated Maturity
Date.
No adjustments to the Exchange Ratio will be required other than those
specified herein. However, the Calculation Agent may, at its sole discretion,
make additional adjustments to the Exchange Ratio to reflect changes occurring
in relation to MeadWestvaco common stock or any other security received in a
reorganization event in other circumstances where the Calculation Agent
determines that it is appropriate to reflect those changes to ensure an
equitable result. The required adjustments specified below do not cover all
events that could affect the closing market price of MeadWestvaco common
stock, including, without limitation, a partial tender or exchange offer for
MeadWestvaco common stock.
The Calculation Agent will be solely responsible for the determination
and calculation of any adjustments to the Exchange Ratio and of any related
determinations and calculations with respect to any distributions of stock,
other securities or other property or assets, including cash, in connection
with any corporate event described below; and its determinations and
calculations will be conclusive absent manifest error.
No adjustments will be made for certain other events, such as offerings
of common stock by MeadWestvaco for cash or in connection with the occurrence
of a partial tender or exchange offer for the common stock by MeadWestvaco.
The Company will, within ten Business Days following the occurrence of an
event that requires an adjustment to the Exchange Ratio, or, if later, within
ten Business Days following the date on which the Company becomes aware of
this occurrence, provide written notice to the Trustee, which will provide
notice to the Holders of the Notes of the occurrence of this event and a
statement in reasonable detail setting forth the adjusted Exchange Ratio.
Stock splits and reverse stock splits
If MeadWestvaco's common stock is subject to a stock split or reverse
stock split, then once any split has become effective, the Exchange Ratio
relating to MeadWestvaco's common stock will be adjusted to equal the product
of the prior Exchange Ratio and the number of shares which a holder of one
share of MeadWestvaco common stock before the effective date of that stock
split or reverse stock split would have owned or been entitled to receive
immediately following the applicable effective date.
Stock dividends
If MeadWestvaco's common stock is subject to a (i) stock dividend, i.e.,
issuance of additional shares of MeadWestvaco's common stock, that is given
ratably to all holders of MeadWestvaco's common stock or (ii) distribution of
shares of MeadWestvaco's common stock as a result of the triggering of any
provision of the corporate charter of MeadWestvaco, then, once the dividend
has become effective and the shares are trading ex-dividend, the Exchange
Ratio will be adjusted so that the new Exchange Ratio shall equal the prior
Exchange Ratio plus the product of:
o the number of the additional shares of MeadWestvaco's common stock
issued with respect to one share of MeadWestvaco's common stock and
o the prior Exchange Ratio.
P-8
Extraordinary Dividends
There will be no adjustments to the Exchange Ratio to reflect any cash
dividends or cash distributions paid with respect to MeadWestvaco's common
stock other than Extraordinary Dividends, as described below, and
distributions described under the section entitled "--Reorganization Events"
below.
An "Extraordinary Dividend" means, with respect to a cash dividend or
other distribution with respect to MeadWestvaco's common stock, a dividend or
other distribution which exceeds the immediately preceding non-Extraordinary
Dividend for MeadWestvaco's common stock (as adjusted for any subsequent
corporate event requiring an adjustment hereunder, such as a stock split or
reverse stock split) by an amount equal to at least 10% of the Closing Market
Price of MeadWestvaco's common stock on the Trading Day preceding the
ex-dividend date with respect to the Extraordinary Dividend (the "ex-dividend
date"). If an Extraordinary Dividend occurs with respect to MeadWestvaco's
common stock, the Exchange Ratio will be adjusted on the ex-dividend date with
respect to the Extraordinary Dividend so that the new Exchange Ratio will
equal the product of:
o the prior Exchange Ratio and
o a fraction, the numerator of which is the Closing Market Price per
share of MeadWestvaco's common stock on the Trading Day preceding
the ex-dividend date, and the denominator of which is the amount by
which the Closing Market Price on the Trading Day preceding the
ex-dividend date exceeds the Extraordinary Dividend Amount.
The "Extraordinary Dividend Amount" with respect to an Extraordinary
Dividend for MeadWestvaco's common stocks will equal:
o in the case of cash dividends or other distributions that constitute
quarterly dividends, the amount per share of that Extraordinary
Dividend minus the amount per share of the immediately preceding
non-Extraordinary Dividend for such shares of MeadWestvaco's common
stock, or
o in the case of cash dividends or other distributions that do not
constitute quarterly dividends, the amount per share of that
Extraordinary Dividend.
To the extent an Extraordinary Dividend is not paid in cash, the value of
the non-cash component will be determined by the Calculation Agent, whose
determination shall be conclusive. A distribution on MeadWestvaco's common
stock described in clause (a), (d) or (e) of the section entitled
"--Reorganization Events" below that also constitutes an Extraordinary
Dividend shall only cause an adjustment pursuant to clause (a), (d) or (e)
under the section entitled "--Reorganization Events". A distribution on
MeadWestvaco's common stock described in the section entitled "--Issuance of
transferable rights or warrants" that also constitutes an Extraordinary
Dividend shall only cause an adjustment pursuant to such section.
Issuance of transferable rights or warrants
If MeadWestvaco issues transferable rights or warrants to all holders of
MeadWestvaco's common stock to subscribe for or purchase MeadWestvaco's common
stock, including new or existing rights to purchase MeadWestvaco's common
stock pursuant to a shareholder's rights plan or arrangement, then the
Exchange Ratio will be adjusted on the Business Day immediately following the
issuance of such transferable rights or warrants so that the new Exchange
Ratio shall equal the prior Exchange Ratio plus the product of:
o the prior Exchange Ratio, and
o the number of MeadWestvaco's common stock that can be purchased with
the cash value of such warrants or rights distributed on one of
MeadWestvaco's common stock.
The number of shares that can be purchased will be based on the Closing Market
Price of MeadWestvaco's common stock on the date the new Exchange Ratio is
determined. The cash value of such warrants or rights, if the warrants or
rights are traded on a national securities exchange, will equal the closing
price of such warrant or right, or, if the warrants or rights are not traded
on a national securities exchange, will be determined by the Calculation Agent
and will equal the average (mean) of the bid prices obtained from three
dealers at 3 p.m. on the date the new Exchange
P-9
Ratio is determined, provided that if only two such bid prices are available,
then the cash value of such warrants or rights will equal the average (mean)
of such bids and if only one such bid is available, then the cash value of
such warrants or rights will equal such bid.
Market Disruption Event
"Market Disruption Event" means:
(1) a suspension of, absence of, including the absence of an official
closing price, or material limitation on, trading of MeadWestvaco's
common stock on the primary market for MeadWestvaco's common stock
for more than two hours of trading or during the one-half hour
period preceding the close of trading, as determined by the
Calculation Agent in its sole discretion; or the suspension or
material limitation on the primary market for trading in options
contracts related to MeadWestvaco's common stock, if available,
during the one-half hour period preceding the close of trading in
the applicable market, in each case as determined by the Calculation
Agent in its sole discretion; and
(2) a determination by the Calculation Agent in its sole discretion that
the event described in clause (1) above materially interfered with
the ability of the Company, the Calculation Agent or any of their
affiliates to unwind all or a material portion of the hedge with
respect to the Notes.
For purposes of determining whether a Market Disruption Event has
occurred:
(1) a limitation on the hours or number of days of trading will not
constitute a Market Disruption Event if it results from an announced
change in the regular business hours of the relevant exchange,
(2) a decision to permanently discontinue trading in the relevant
options contracts related to MeadWestvaco's common stock will not
constitute a Market Disruption Event,
(3) limitations pursuant to any rule or regulation enacted or
promulgated by the NYSE or The Nasdaq Stock Market or other
regulatory organization with jurisdiction over the NYSE or The
Nasdaq Stock Market on trading during significant market
fluctuations will constitute a suspension or material limitation of
trading in MeadWestvaco's common stock,
(4) a suspension of trading in an options contract on MeadWestvaco's
common stock by the primary securities market trading in the options
contracts related to MeadWestvaco's common stock, if available, by
reason of:
o a price change exceeding limits set by the securities exchange
or market,
o an imbalance of orders relating to options contracts on
MeadWestvaco's common stock, or
o a disparity in bid and ask quotes relating to options contracts
on MeadWestvaco's common stock
will constitute a suspension or material limitation of trading in
options contracts related to MeadWestvaco's common stock, and
(5) a suspension of, absence of or material limitation on trading on the
primary securities market on which options contracts related to
MeadWestvaco's common stock are traded will not include any time
when that securities market is itself closed for trading under
ordinary circumstances.
If Exchange Property, as described below, includes securities other than
MeadWestvaco's common stock, then the above definition shall be revised to
include each such security in the same manner as MeadWestvaco's common stock
are considered in determining whether a Market Disruption Event exists.
P-10
Reorganization Events
If prior to the maturity date of the Notes,
(a) there occurs any reclassification or change of MeadWestvaco's common
stock, including, without limitation, as a result of the issuance of
tracking stock by MeadWestvaco,
(b) MeadWestvaco, or any surviving entity or subsequent surviving entity
of MeadWestvaco (a "Successor Entity"), has been subject to a
merger, combination or consolidation and is not the surviving
entity,
(c) any statutory exchange of securities of MeadWestvaco or any
Successor Entity with another corporation occurs, other than
pursuant to clause (b) above,
(d) MeadWestvaco is liquidated or is subject to a proceeding under any
applicable bankruptcy, insolvency or other similar law,
(e) MeadWestvaco issues to all of its shareholders equity securities of
an issuer other than MeadWestvaco, other than in a transaction
described in clauses (b), (c) or (d) above (a "Spin-off Event"), or
(f) a tender or exchange offer or going-private transaction is
consummated for all the outstanding shares of MeadWestvaco (an event
in clauses (a) through (f) a "Reorganization Event"),
then the method of determining the amount payable on each Note will be
adjusted as set forth below.
"Exchange Property" will consist of any MeadWestvaco's common stock
continued to be held by the holders of MeadWestvaco's common stock, and any
securities, cash or any other assets distributed to the holders of
MeadWestvaco's common stock with respect to one share in or as a result of the
Reorganization Event. No interest will accrue on any Exchange Property.
If a Reorganization Event occurs, then the Exchange Price and Call Price
shall be calculated by using the value of the Exchange Property in place of
the Exchange Value and such value shall be calculated as the sum of the value
of the components of the Exchange Property as described below:
o If the Exchange Property is securities (including without
limitation, securities of MeadWestvaco) traded on the New York Stock
Exchange, American Stock Exchange or Nasdaq National Market
("Exchange Traded Securities"), the value of such Exchange Property
will equal the Closing Market Price of the securities composing the
Exchange Property.
o If the Exchange Property consists of cash, other property that is
not Exchange Traded Securities or a combination thereof, the
Calculation Agent shall value as if liquidated on the date received
all such non-cash Exchange Property upon terms that it deems
commercially reasonable, and the value of that Exchange Property
shall equal the aggregate cash amount, including the amount
resulting from such valuation.
In the event Exchange Property consists of securities, those securities
will, in turn, be subject to the anti-dilution adjustments contained herein.
In the case of a consummated tender or exchange offer or going-private
transaction involving Exchange Property of a particular type, Exchange
Property shall be deemed to include the amount of cash or other property paid
by the offer or in the tender or exchange offer with respect to such Exchange
Property (in an amount determined on the basis of the rate of exchange in such
tender or exchange offer or going-private transaction). In the event of a
tender or exchange offer or a going-private transaction with respect to
Exchange Property in which an offeree may elect to receive cash or other
property, Exchange Property shall be deemed to include the kind and amount of
cash and other property received by offerees who elect to receive cash.
The Calculation Agent shall be solely responsible for determination and
calculation of the Exchange Property if a Reorganization Event occurs and the
cash amount due upon exchange, including the determination of
P-11
the cash value of any Exchange Property and the Per Share Liquidation Value,
if necessary. Its determinations and calculations shall be conclusive absent
manifest error.
Alternative Dilution and Reorganization Adjustments
The Calculation Agent may elect at its discretion to not make any of the
adjustments to the Exchange Ratio or to the method of determining the amount
payable on each Note described above under "Exchange Ratio Adjustments" and
"Reorganization Events", but may instead make adjustments in its discretion to
the Exchange Ratio or the method of determining the amount payable on each
Note that will reflect the adjustments to the extent practicable made by the
Options Clearing Corporation on option contracts on MeadWestvaco's common
stock or any successor common stock. The Company will provide notice of any
such election to the trustee not more than two Business Days following the
date that the Options Clearing Corporation publishes notice of its adjustments
relating to the Shares and will detail in such notice the actual adjustment
made to the Exchange Ratio or to the method of determining the amount payable
on each Note.
EVENTS OF DEFAULT AND ACCELERATION
In case an Event of Default with respect to any Notes has occurred and is
continuing, the amount payable to a beneficial owner of a Note upon any
acceleration permitted by the Notes will be an amount equal to the Exchange
Price of the Notes calculated as though the third Trading Day prior to the
date of early repayment were the relevant Exchange Date, all as determined by
the Calculation Agent. If a bankruptcy proceeding is commenced in respect of
ML&Co., the claim of the beneficial owner of the Notes may be limited, under
Section 502(b)(2) of Title 11 of the United States Code, to the principal
amount of the Notes plus an additional amount of contingent interest
calculated as though the date of the commencement of the proceeding were the
maturity date of the Notes.
In case of default in payment of the Notes, whether at any interest
payment date, the Stated Maturity Date, the Call Date, the Exchange Date, the
date of early redemption due to a Reorganization Event or upon acceleration,
from and after that date the Notes will bear interest, payable upon demand of
their beneficial owners, at the rate of 1.36% per year, to the extent that
payment of such interest shall be legally enforceable, on the unpaid amount
due and payable on that date in accordance with the terms of the Notes to the
date payment of that amount has been made or duly provided for.
MEADWESTVACO COMMON STOCK
MeadWestvaco
The following information has been derived from publicly available
documents published by MeadWestvaco. We make no representation or warranty as
to the accuracy or completeness of the following information.
MeadWestvaco has disclosed that its principal operating business
segments are packaging, paper, consumer and office products and specialty
chemicals. Because MeadWestvaco common stock is registered under the
Securities Exchange Act of 1934, MeadWestvaco is required to file periodically
certain financial and other information specified by the SEC. Information
provided to or filed with the SEC by MeadWestvaco Corporation can be located
at the SEC's facilities or through the SEC's web site by reference to SEC file
number 001-31215. See "Where You Can Find More Information". ML&Co. makes no
representation or warranty as to the accuracy or completeness of the
information or reports.
The selection of MeadWestvaco is not a recommendation to buy or sell
MeadWestvaco common stock. Neither ML&Co. nor any of its affiliates make any
representation to any purchaser of the Notes as to the performance of
MeadWestvaco common stock.
MeadWestvaco common stock trades on the New York Stock Exchange
under the symbol "MWV".
P-12
ML&Co. is not affiliated with MeadWestvaco. MeadWestvaco has no
obligations with respect to the Notes. This prospectus supplement relates only
to the Notes and does not relate to MeadWestvaco common stock or other
securities of MeadWestvaco. All disclosures contained in this prospectus
supplement regarding MeadWestvaco are derived from the publicly available
documents described above. Neither ML&Co. nor MLPF&S has participated in the
preparation of these documents or made any due diligence inquiry with respect
to MeadWestvaco in connection with the offering of the Notes. Neither ML&Co.
nor MLPF&S makes any representation that the publicly available documents or
any other publicly available information regarding MeadWestvaco are accurate
or complete. Furthermore, there can be no assurance that all events occurring
prior to the date hereof, including events that would affect the accuracy or
completeness of the publicly available documents described above, that would
affect the trading price of MeadWestvaco common stock have been publicly
disclosed. Subsequent disclosure of any events or the disclosure of or failure
to disclose material future events concerning MeadWestvaco could affect the
value of MeadWestvaco common stock to be received at maturity of the Notes and
therefore the trading prices of the Notes. Neither ML&Co. nor any of its
affiliates make any representation to any purchaser of the Notes as to the
performance of MeadWestvaco common stock.
ML&Co. or its affiliates may presently or from time to time engage
in business, directly or indirectly, with MeadWestvaco including extending
loans to, or making equity investments in, MeadWestvaco or providing
investment banking or advisory services to MeadWestvaco, including merger and
acquisition advisory services. In the course of such business, ML&Co. or its
affiliates may acquire non-public information with respect to MeadWestvaco
and, in addition, one or more affiliates of ML&Co. may publish research
reports with respect to MeadWestvaco.
Any prospective purchaser of the Notes should undertake an
independent investigation of MeadWestvaco as in its judgment is appropriate to
make an informed decision with respect to an investment in MeadWestvaco.
Historical Data
MeadWestvaco common stock is principally traded on the New York
Stock Exchange. The following table sets forth the high and low closing prices
for the calendar quarters during calendar years 2002 through 2003. On July 22,
2003, the closing price for MeadWestvaco common stock was $23.89 per share.
The closing prices listed below were obtained from Bloomberg Financial
Markets. MeadWestvaco Corporation was formed as a result of a merger of The
Mead Corporation and Westvaco Corporation, completed on January 29, 2002.
Consequently, prior to this date, historical closing prices for MeadWestvaco
common stock are not available. The historical closing prices of MeadWestvaco
common stock should not be taken as an indication of future performance, and
no assurance can be given that the price of MeadWestvaco common stock will not
decrease. In addition, no assurance can be given that the price of
MeadWestvaco common stock will increase above the issue price so that at
maturity the beneficial owners of the Notes will receive cash in an amount in
excess of the principal amount of the Notes.
High Low
---- ---
2002
First Quarter........................................ $36.40 $31.55
Second Quarter....................................... $33.56 $28.58
Third Quarter........................................ $32.90 $19.21
Fourth Quarter....................................... $25.04 $15.70
2003
First Quarter........................................ $26.51 $21.69
Second Quarter ...................................... $26.10 $22.31
Third Quarter (through July 22, 2003)................ $24.75 $23.65
P-13
UNITED STATES FEDERAL INCOME TAXATION
Set forth in full below is the opinion of Sidley Austin Brown & Wood LLP,
counsel to ML&Co., as to certain United States Federal income tax consequences
of the purchase, ownership and disposition of the Notes. This opinion is based
upon laws, regulations, rulings and decisions now in effect, all of which are
subject to change (including retroactive changes in effective dates) or
possible differing interpretations. The discussion below deals only with Notes
held as capital assets and does not purport to deal with persons in special
tax situations, such as financial institutions, insurance companies, regulated
investment companies, dealers in securities or currencies, traders in
securities that elect to mark to market, tax-exempt entities, persons holding
Notes in a tax-deferred or tax-advantaged account, or persons holding Notes as
a hedge against currency risks, as a position in a "straddle" or as part of a
"hedging" or "conversion" transaction for tax purposes. It also does not deal
with holders other than original purchasers (except where otherwise
specifically noted in this Pricing Supplement). The following discussion also
assumes that the issue price of the Notes, as determined for United States
Federal income tax purposes, equals the principal amount thereof. Persons
considering the purchase of the Notes should consult their own tax advisors
concerning the application of the United States Federal income tax laws to
their particular situations as well as any consequences of the purchase,
ownership and disposition of the Notes arising under the laws of any other
taxing jurisdiction.
As used in this Pricing Supplement, the term "U.S. Holder" means a
beneficial owner of a Note that is for United States Federal income tax
purposes (a) a citizen or resident of the United States, (b) a corporation,
partnership or other entity treated as a corporation or a partnership created
or organized in or under the laws of the United States, any state thereof or
the District of Columbia (other than a partnership that is not treated as a
United States person under any applicable Treasury regulations), (c) an estate
the income of which is subject to United States Federal income taxation
regardless of its source, (d) a trust if a court within the United States is
able to exercise primary supervision over the administration of the trust and
one or more United States persons have the authority to control all
substantial decisions of the trust, or (e) any other person whose income or
gain in respect of a Note is effectively connected with the conduct of a
United States trade or business. Notwithstanding clause (d) of the preceding
sentence, to the extent provided in Treasury regulations, certain trusts in
existence on August 20, 1996, and treated as United States persons prior to
that date that elect to continue to be treated as United States persons also
will be U.S. Holders. As used herein, the term "non-U.S. Holder" means a
beneficial owner of a Note that is not a U.S. Holder.
General
There are no statutory provisions, regulations, published rulings or
judicial decisions addressing or involving the characterization, for United
States Federal income tax purposes, of the Notes or securities with terms
substantially the same as the Notes. However, although the matter is not free
from doubt, under current law, each Note should be treated as a debt
instrument of ML&Co. for United States Federal income tax purposes. ML&Co.
currently intends to treat each Note as a debt instrument of ML&Co. for United
States Federal income tax purposes and, where required, intends to file
information returns with the Internal Revenue Service (the "IRS") in
accordance with this treatment, in the absence of any change or clarification
in the law, by regulation or otherwise, requiring a different characterization
of the Notes. Prospective investors in the Notes should be aware, however,
that the IRS is not bound by ML&Co.'s characterization of the Notes as
indebtedness, and the IRS could possibly take a different position as to the
proper characterization of the Notes for United States Federal income tax
purposes. The following discussion of the principal United States Federal
income tax consequences of the purchase, ownership and disposition of the
Notes is based upon the assumption that each Note will be treated as a debt
instrument of ML&Co. for United States Federal income tax purposes. If the
Notes are not in fact treated as debt instruments of ML&Co. for United States
Federal income tax purposes, then the United States Federal income tax
treatment of the purchase, ownership and disposition of the Notes could differ
from the treatment discussed below with the result that the timing and
character of income, gain or loss recognized in respect of a Note could differ
from the timing and character of income, gain or loss recognized in respect of
a Note had the Notes in fact been treated as debt instruments of ML&Co. for
United States Federal income tax purposes.
P-14
U.S. Holders
On July 11, 1996, the Treasury Department issued final regulations (the
"Final Regulations") concerning the proper United States Federal income tax
treatment of contingent payment debt instruments such as the Notes, which
apply to debt instruments issued on or after August 13, 1996 and, accordingly,
will apply to the Notes. In general, the Final Regulations cause the timing
and character of income, gain or loss reported on a contingent payment debt
instrument to substantially differ from the timing and character of income,
gain or loss reported on a contingent payment debt instrument under general
principles of prior United States Federal income tax law. Specifically, the
Final Regulations generally require a U.S. Holder of such an instrument to
include future contingent and noncontingent interest payments in income as
that interest accrues based upon a projected payment schedule. Moreover, in
general, under the Final Regulations, any gain recognized by a U.S. Holder on
the sale, exchange, or retirement of a contingent payment debt instrument is
treated as ordinary income, and all or a portion of any loss realized could be
treated as ordinary loss as opposed to capital loss (depending upon the
circumstances). The Final Regulations provide no definitive guidance as to
whether or not an instrument is properly characterized as a debt instrument
for United States Federal income tax purposes.
In particular, solely for purposes of applying the Final Regulations to
the Notes, ML&Co. has determined that the projected payment schedule for the
Notes will consist of the stated semi-annual interest payments on the Notes
(other than the stated semi-annual interest payment due on the Stated Maturity
Date) and a payment immediately prior to the Stated Maturity Date taking into
account the exchange feature of an amount equal to $1,334.8750 per Note (the
"Projected Exchange Amount"). This represents an estimated yield on the Notes
equal to 4.375% per annum, compounded semi-annually. Accordingly, during the
term of the Notes, a U.S. Holder of a Note will be required to include in
income as ordinary interest an amount equal to the sum of the daily portions
of interest on the Note that are deemed to accrue at this estimated yield for
each day during the taxable year (or portion of the taxable year) on which the
U.S. Holder holds the Note. The amount of interest that will be deemed to
accrue in any accrual period (i.e., generally each six-month period during
which the Notes are outstanding) will equal the product of this estimated
yield (properly adjusted for the length of the accrual period) and the Note's
adjusted issue price (as defined below) at the beginning of the accrual
period. The daily portions of interest will be determined by allocating to
each day in the accrual period the ratable portion of the interest that is
deemed to accrue during the accrual period. In general, for these purposes a
Note's adjusted issue price will equal the Note's Issue Price (i.e., $1,000),
increased by the interest previously accrued on the Note and decreased by the
amount of any stated semi-annual interest payments previously made on the
Note. As a result of the foregoing rules, a U.S. Holder will not be required
to separately include in income the stated semi-annual interest payments
received on a Note. At maturity of a Note, since the amount payable to a U.S.
Holder (including any payment of stated semi-annual interest) on the Stated
Maturity Date (the "Actual Redemption Amount") with respect to a Note will be
less than $1,334.8750 per Note (i.e., the Projected Exchange Amount), the
excess of $1,334.8750 per Note (i.e., the Projected Exchange Amount) over the
Actual Redemption Amount will be treated first as an offset to any interest
otherwise includible in income by the U.S. Holder with respect to the Note for
the taxable year in which the Stated Maturity Date occurs to the extent of the
amount of that includible interest. Any remaining portion of the Projected
Exchange Amount (i.e., $1,334.8750 per Note) in excess of the Actual
Redemption Amount that is not treated as an interest offset pursuant to the
foregoing rules generally will be an ordinary loss to the extent of interest
previously included in income, and thereafter, capital loss. Any such capital
loss generally will be treated as long-term or short-term capital loss
(depending upon the U.S. Holder's holding period for the Note). In addition,
U.S. Holders purchasing a Note at a price that differs from the adjusted issue
price of the Note as of the purchase date (e.g., subsequent purchasers) will
be subject to rules providing for certain adjustments to the foregoing rules
and these U.S. Holders should consult their own tax advisors concerning these
rules.
Upon the sale, redemption, or exchange of a Note prior to the Stated
Maturity Date, a U.S. Holder will be required to recognize taxable gain or
loss in an amount equal to the difference, if any, between the amount realized
by the U.S. Holder upon such sale, redemption, or exchange and the U.S.
Holder's adjusted tax basis in the Note as of the date of disposition. A U.S.
Holder's adjusted tax basis in a Note generally will equal such U.S. Holder's
initial investment in the Note increased by any interest previously included
in income with respect to the Note by the U.S. Holder and reduced by any
stated semi-annual interest payments received on the Note by the U.S. Holder.
Any taxable gain will be treated as ordinary income. Any taxable loss will be
treated as ordinary loss to the extent of the U.S. Holder's total interest
inclusions on the Note. Any remaining loss generally will be treated as
long-term or short-term capital loss (depending upon the U.S. Holder's holding
period for the Note). All amounts includible in income by a U.S. Holder as
ordinary interest pursuant to the Final Regulations will be treated as
original issue discount.
P-15
All prospective investors in the Notes should consult their own tax
advisors concerning the application of the Final Regulations to their
investment in the Notes. Investors in the Notes may also obtain the projected
payment schedule, as determined by ML&Co. for purposes of applying the Final
Regulations to the Notes, by submitting a written request for such information
to Merrill Lynch & Co., Inc., Corporate Secretary's Office, 222 Broadway, 17th
Floor, New York, New York 10038, (212) 670-0432,
corporatesecretary@exchange.ml.com.
The projected payment schedule (including both the Projected Exchange
Amount and the estimated yield on the Notes) has been determined solely for
United States Federal income tax purposes (i.e., for purposes of applying the
Final Regulations to the Notes), and is neither a prediction nor a guarantee
regarding the actual amounts payable on the Notes.
The following table sets forth the amount of interest that will be deemed
to have accrued with respect to each Note during each accrual period over the
term of the Notes based upon the projected payment schedule for the Notes
(including both the Projected Exchange Amount and an estimated yield equal to
4.375% (compounded semi-annually)) as determined by ML&Co. for purposes of
applying the Final Regulations to the Notes:
Total interest deemed
Interest deemed to to have accrued on a
accrue on a Note Note
during accrual as of end of
period accrual period
Accrual Period (per $1,000 Note) (per $1,000 Note)
- ----------------------------------------------------------------- ---------------------- ------------------------
July 28, 2003 through January 28, 2004....................... $21.8750 $21.8750
January 29, 2004 through July 28, 2004....................... $22.3262 $44.2012
July 29, 2004 through January 28, 2005....................... $22.7872 $66.9884
January 29, 2005 through July 28, 2005....................... $23.2583 $90.2467
July 29, 2005 through January 28, 2006....................... $23.7398 $113.9865
January 29, 2006 through July 28, 2006....................... $24.2317 $138.2182
July 29, 2006 through January 28, 2007....................... $24.7345 $162.9527
January 29, 2007 through July 28, 2007....................... $25.2482 $188.2009
July 29, 2007 through January 28, 2008....................... $25.7731 $213.9740
January 29, 2008 through July 28, 2008....................... $26.3096 $240.2836
July 29, 2008 through January 28, 2009....................... $26.8578 $267.1414
January 29, 2009 through July 28, 2009....................... $27.4179 $294.5593
July 29, 2009 through January 28, 2010....................... $27.9904 $322.5497
January 29, 2010 through July 27, 2010....................... $28.5753 $351.1250
- -----------------
Projected Exchange Amount= $1,334.8750 per unit.
Non-U.S. Holders
A non-U.S. Holder will not be subject to United States Federal income
taxes on payments of principal, premium (if any) or interest (including
original issue discount, if any) on a Note, unless such non-U.S. Holder is a
direct or indirect 10% or greater shareholder of ML&Co., a controlled foreign
corporation related to ML&Co. or a bank receiving interest described in
section 881(c)(3)(A) of the Internal Revenue Code of 1986, as amended.
However, income allocable to non-U.S. Holders will generally be subject to
annual tax reporting on IRS Form 1042-S. For a non-U.S. Holder to qualify for
the exemption from taxation, any person, U.S. or foreign, that has control,
receipt, or custody of an amount subject to withholding, or who can disburse
or make payments of an amount subject to withholding (the "Withholding Agent")
must have received a statement that (a) is signed by the beneficial owner of
the Note under penalties of perjury, (b) certifies that such owner is a
non-U.S. Holder and (c) provides the name and address of the beneficial owner.
The statement may generally be made on IRS Form W-8BEN (or other applicable
form) or a substantially similar form, and the beneficial owner must inform
the Withholding Agent of any change in the information on the statement within
30 days of that change by filing a new IRS Form W-8BEN (or other applicable
form). Generally, an IRS Form W-8BEN provided without a U.S. taxpayer
identification number will remain in effect for a period starting on the date
the form is signed and ending on the last day of the third
P-16
succeeding calendar year, unless a change in circumstances makes any
information on the form incorrect. If a Note is held through a securities
clearing organization or certain other financial institutions, the
organization or institution may provide a signed statement to the Withholding
Agent. Under certain circumstances, the signed statement must be accompanied
by a copy of the applicable IRS Form W-8BEN (or other applicable form) or the
substitute form provided by the beneficial owner to the organization or
institution.
Under current law, a Note will not be includible in the estate of a
non-U.S. Holder unless the individual is a direct or indirect 10% or greater
shareholder of ML&Co. or, at the time of such individual's death, payments in
respect of such Note would have been effectively connected with the conduct by
such individual of a trade or business in the United States.
Backup withholding
Backup withholding at the applicable statutory rate of United States
Federal income tax may apply to payments made in respect of the Notes to
registered owners who are not "exempt recipients" and who fail to provide
certain identifying information (such as the registered owner's taxpayer
identification number) in the required manner. Generally, individuals are not
exempt recipients, whereas corporations and certain other entities generally
are exempt recipients. Payments made in respect of the Notes to a U.S. Holder
must be reported to the IRS, unless the U.S. Holder is an exempt recipient or
establishes an exemption. Compliance with the identification procedures
described in the preceding section would establish an exemption from backup
withholding for those non-U.S. Holders who are not exempt recipients.
In addition, upon the sale of a Note to (or through) a broker, the broker
must withhold on the entire purchase price, unless either (a) the broker
determines that the seller is a corporation or other exempt recipient or (b)
the seller provides, in the required manner, certain identifying information
(e.g., an IRS Form W-9) and, in the case of a non-U.S. Holder, certifies that
such seller is a non-U.S. Holder (and certain other conditions are met). Such
a sale must also be reported by the broker to the IRS, unless either (a) the
broker determines that the seller is an exempt recipient or (b) the seller
certifies its non-U.S. status (and certain other conditions are met).
Certification of the registered owner's non-U.S. status would be made normally
on an IRS Form W-8BEN (or other applicable form) under penalties of perjury,
although in certain cases it may be possible to submit other documentary
evidence.
Any amounts withheld under the backup withholding rules from a payment to
a beneficial owner would be allowed as a refund or a credit against such
beneficial owner's United States Federal income tax provided the required
information is furnished to the IRS.
ERISA CONSIDERATIONS
Each fiduciary of a pension, profit-sharing or other employee benefit
plan (a "plan") subject to the Employee Retirement Income Security Act of
1974, as amended ("ERISA"), should consider the fiduciary standards of ERISA
in the context of the plan's particular circumstances before authorizing an
investment in the Notes. Accordingly, among other factors, the fiduciary
should consider whether the investment would satisfy the prudence and
diversification requirements of ERISA and would be consistent with the
documents and instruments governing the plan, and whether the investment would
involve a prohibited transaction under Section 406 of ERISA or Section 4975 of
the Internal Revenue Code (the "Code").
Section 406 of ERISA and Section 4975 of the Code prohibit plans, as well
as individual retirement accounts and Keogh plans subject to Section 4975 of
the Internal Revenue Code (also "plans") from engaging in certain transactions
involving "plan assets" with persons who are "parties in interest" under ERISA
or "disqualified persons" under the Code ("parties in interest") with respect
to the plan or account. A violation of these prohibited transaction rules may
result in civil penalties or other liabilities under ERISA and/or an excise
tax under Section 4975 of the Code for those persons, unless exemptive relief
is available under an applicable statutory, regulatory or administrative
exemption. Certain employee benefit plans and arrangements including those
that are governmental plans (as defined in section 3(32) of ERISA), certain
church plans (as defined in Section 3(33) of ERISA) and foreign plans (as
described in Section 4(b)(4) of ERISA) ("non-ERISA arrangements") are not
subject to the requirements of ERISA or Section 4975 of the Code but may be
subject to similar provisions under applicable federal, state, local, foreign
or other regulations, rules or laws ("similar laws").
P-17
The acquisition of the Notes by a plan with respect to which we, MLPF&S,
or certain of our affiliates is or becomes a party in interest may constitute
or result in prohibited transaction under ERISA or Section 4975 of the Code,
unless those Notes are acquired pursuant to and in accordance with an
applicable exemption. The U.S. Department of Labor has issued five prohibited
transaction class exemptions, or "PTCEs", that may provide exemptive relief if
required for direct or indirect prohibited transactions that may arise from
the purchase or holding of the Notes. These exemptions are:
(1) PTCE 84-14, an exemption for certain transactions determined or
effected by independent qualified professional asset managers;
(2) PTCE 90-1, an exemption for certain transactions involving insurance
company pooled separate accounts;
(3) PTCE 91-38, an exemption for certain transactions involving bank
collective investment funds;
(4) PTCE 95-60, an exemption for transactions involving certain
insurance company general accounts; and
(5) PTCE 96-23, an exemption for plan asset transactions managed by
in-house asset managers.
The Notes may not be purchased or held by (1) any plan, (2) any entity
whose underlying assets include "plan assets" by reason of any plan's
investment in the entity (a "plan asset entity") or (3) any person investing
"plan assets" of any plan, unless in each case the purchaser or holder is
eligible for the exemptive relief available under one or more of the PTCEs
listed above or another applicable similar exemption. Any purchaser or holder
of the Notes or any interest in the Notes will be deemed to have represented
by its purchase and holding of the Notes that it either (1) is not a plan or a
plan asset entity and is not purchasing those Notes on behalf of or with "plan
assets" of any plan or plan asset entity or (2) with respect to the purchase
or holding, is eligible for the exemptive relief available under any of the
PTCEs listed above or another applicable exemption. In addition, any purchaser
or holder of the Notes or any interest in the Notes which is a non-ERISA
arrangement will be deemed to have represented by its purchase and holding of
the Notes that its purchase and holding will not violate the provisions of any
similar law.
Due to the complexity of these rules and the penalties that may be
imposed upon persons involved in non-exempt prohibited transactions, it is
important that fiduciaries or other persons considering purchasing the Notes
on behalf of or with "plan assets" of any plan, plan asset entity or non-ERISA
arrangement consult with their counsel regarding the availability of exemptive
relief under any of the PTCEs listed above or any other applicable exemption,
or the potential consequences of any purchase or holding under similar laws,
as applicable.
WHERE YOU CAN FIND MORE INFORMATION
ML&Co.
We file reports, proxy statements and other information with the
SEC. Our SEC filings are also available over the Internet at the SEC's web
site at http://www.sec.gov. The address of the SEC's Internet site is provided
solely for the information of prospective investors and is not intended to be
an active link. You may also read and copy any document we file by visiting
the SEC's public reference rooms in Washington, D.C., and New York, New York.
Please call the SEC at 1-800-SEC-0330 for further information about the public
reference rooms and their copy charges. You may also inspect our SEC reports
and other information at the New York Stock Exchange, Inc., 20 Broad Street,
New York, New York 10005.
We have filed a registration statement on Form S-3 with the SEC
covering the Notes and other securities. For further information on ML&Co. and
the Notes, you should refer to our registration statement and its exhibits.
The prospectus supplement and prospectus accompanying this pricing supplement
summarizes material provisions of contracts and other documents that we refer
you to. Because the prospectus and prospectus supplement may not contain all
the information that you may find important, you should review the full text
of these documents. We have included copies of these documents as exhibits to
our registration statement.
You should rely only on the information contained or incorporated by
reference in this pricing supplement, prospectus supplement and in the
accompanying prospectus. We have not, and the underwriter has not,
P-18
authorized any other person to provide you with different information. If
anyone provides you with different or inconsistent information, you should not
rely on it. We are not, and the underwriter is not, making an offer to sell
these securities in any jurisdiction where the offer or sale is not permitted.
You should assume that the information appearing in this pricing
supplement, prospectus supplement and in the accompanying prospectus is
accurate as of the date on the front cover of this pricing supplement only.
Our business, financial condition and results of operations may have changed
since that date.
MeadWestvaco Corporation
MeadWestvaco files reports, proxy statements and other information with
the SEC. Information provided to or filed with the SEC by MeadWestvaco
pursuant to the Securities Exchange Act of 1934 can be located at the SEC's
facilities or accessed through the SEC's web site by reference to SEC file
number 001-31215. You may also inspect MeadWestvaco's SEC reports and other
information at the Nasdaq National Market. In addition, information regarding
MeadWestvaco may be obtained from other sources including, but not limited to,
press releases, newspaper articles and other publicly disseminated documents.
We make no representation or warranty as to the accuracy or completeness of
the information or reports.
Plan of Distribution
As described in the "Plan of Distribution" in the attached Prospectus
Supplement, MLPF&S is purchasing the Notes, as principal, from ML&Co., for
resale to investors and other purchasers at the Issue Price set forth on the
cover of this Pricing Supplement. After the initial public offering, the Issue
Price may be changed.
P-19